{"id":962040,"date":"2026-05-13T07:18:25","date_gmt":"2026-05-13T11:18:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/"},"modified":"2026-05-13T07:18:25","modified_gmt":"2026-05-13T11:18:25","slug":"ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/","title":{"rendered":"Ocugen to Participate in Upcoming May Scientific and Investor Conferences"},"content":{"rendered":"
\n

MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming scientific and investor conferences in May 2026.<\/p>\n

\n
\n Retina World Congress <\/u>
\n <\/strong>\n <\/p>\n

Inherited and Rare Retinal Diseases Session
Moderators: Kourous A. Rezaei, MD and Rishi P. Singh, MD, FASRS
Location: Grand Ballroom
Date: Thursday, May 14, 2026
Time: 10:31 am \u2013 11:10 a.m. EDT<\/p>\n

\n
\n Stifel 2026 Virtual Ophthalmology Forum<\/u>
\n <\/strong>\n <\/p>\n

Location: Virtual
Date: Tuesday, May 26, 2026
Time: 10:30 am \u2013 10:55 a.m. EDT<\/p>\n

A webcast of the Stifel presentation will be available under the \u201cEvents and Presentation\u201d page of the Investors section of the Company\u2019s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit\u00a0Investors | Ocugen, Inc.<\/a><\/p>\n

\n About<\/strong>
\n Ocugen,<\/strong>
\n Inc<\/strong>.
Ocugen, Inc. is a pioneering biotechnology leader in gene therapies for blindness diseases. Our breakthrough modifier gene therapy platform has the potential to address significant unmet medical need for large patient populations through our gene-agnostic approach. Unlike traditional gene therapies and gene editing, Ocugen\u2019s modifier gene therapies address the entire disease\u2014complex diseases that are potentially caused by imbalances in multiple gene networks. Currently we have programs in development for inherited retinal diseases and blindness diseases affecting millions across the globe, including retinitis pigmentosa, Stargardt disease, and geographic atrophy\u2014late-stage dry age-related macular degeneration. Discover more at\u00a0www.ocugen.com<\/a>\u00a0and follow us on\u00a0X<\/a>\u00a0and\u00a0LinkedIn<\/a>.<\/p>\n

\n Cautionary<\/strong>
\n Note<\/strong>
\n on<\/strong>
\n Forward-Looking<\/strong>
\n Statements<\/strong>
\n
\n This<\/em>
\n press<\/em>
\n release<\/em>
\n contains<\/em>
\n forward-looking<\/em>
\n statements<\/em>
\n within<\/em>
\n the<\/em>
\n meaning<\/em>
\n of<\/em>
\n The<\/em>
\n Private<\/em>
\n Securities<\/em>
\n Litigation<\/em>
\n Reform<\/em>
\n Act<\/em>
\n of<\/em>
\n 1995,<\/em>
\n including,<\/em>
\n but<\/em>
\n not limited to, statements regarding qualitative assessments of available data, potential benefits, expectations for ongoing clinical trials, anticipated regulatory<\/em>
\n filings<\/em>
\n and<\/em>
\n anticipated<\/em>
\n development<\/em>
\n timelines,<\/em>
\n which<\/em>
\n are<\/em>
\n subject<\/em>
\n to<\/em>
\n risks<\/em>
\n and<\/em>
\n uncertainties.<\/em>
\n We<\/em>
\n may,<\/em>
\n in<\/em>
\n some<\/em>
\n cases,<\/em>
\n use<\/em>
\n terms<\/em>
\n such<\/em>
\n as <\/em>
\n \u201cpredicts,\u201d \u201cbelieves,\u201d \u201cpotential,\u201d \u201cproposed,\u201d \u201ccontinue,\u201d \u201cestimates,\u201d \u201canticipates,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d<\/em>
\n or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations, including,<\/em>
\n but<\/em>
\n not<\/em>
\n limited<\/em>
\n to,<\/em>
\n the<\/em>
\n risks<\/em>
\n that<\/em>
\n preliminary,<\/em>
\n interim<\/em>
\n and<\/em>
\n top-line<\/em>
\n clinical<\/em>
\n trial<\/em>
\n results<\/em>
\n may<\/em>
\n not<\/em>
\n be<\/em>
\n indicative<\/em>
\n of,<\/em>
\n and<\/em>
\n may<\/em>
\n differ<\/em>
\n from,<\/em>
\n final<\/em>
\n clinical data;<\/em>
\n that<\/em>
\n unfavorable<\/em>
\n new<\/em>
\n clinical<\/em>
\n trial<\/em>
\n data<\/em>
\n may<\/em>
\n emerge<\/em>
\n in<\/em>
\n ongoing<\/em>
\n clinical<\/em>
\n trials<\/em>
\n or<\/em>
\n through<\/em>
\n further<\/em>
\n analyses<\/em>
\n of<\/em>
\n existing<\/em>
\n clinical<\/em>
\n trial<\/em>
\n data;<\/em>
\n that<\/em>
\n earlier non-clinical<\/em>
\n and<\/em>
\n clinical<\/em>
\n data<\/em>
\n and<\/em>
\n testing<\/em>
\n of<\/em>
\n may<\/em>
\n not<\/em>
\n be<\/em>
\n predictive<\/em>
\n of<\/em>
\n the<\/em>
\n results<\/em>
\n or<\/em>
\n success<\/em>
\n of<\/em>
\n later<\/em>
\n clinical<\/em>
\n trials;<\/em>
\n and<\/em>
\n that<\/em>
\n that<\/em>
\n clinical<\/em>
\n trial<\/em>
\n data<\/em>
\n are subject<\/em>
\n to<\/em>
\n differing<\/em>
\n interpretations<\/em>
\n and<\/em>
\n assessments,<\/em>
\n including<\/em>
\n by<\/em>
\n regulatory<\/em>
\n authorities. These<\/em>
\n and other<\/em>
\n risks and<\/em>
\n uncertainties<\/em>
\n are more fully described<\/em>
\n in<\/em>
\n our<\/em>
\n periodic<\/em>
\n filings<\/em>
\n with<\/em>
\n the<\/em>
\n Securities<\/em>
\n and<\/em>
\n Exchange<\/em>
\n Commission<\/em>
\n (SEC),<\/em>
\n including<\/em>
\n the<\/em>
\n risk<\/em>
\n factors<\/em>
\n described<\/em>
\n in<\/em>
\n the<\/em>
\n section<\/em>
\n entitled<\/em>
\n \u201cRisk Factors\u201d<\/em>
\n in<\/em>
\n the<\/em>
\n quarterly<\/em>
\n and<\/em>
\n annual<\/em>
\n reports<\/em>
\n that<\/em>
\n we<\/em>
\n file<\/em>
\n with<\/em>
\n the<\/em>
\n SEC.<\/em>
\n Any<\/em>
\n forward-looking<\/em>
\n statements<\/em>
\n that<\/em>
\n we<\/em>
\n make<\/em>
\n in<\/em>
\n this<\/em>
\n press<\/em>
\n release<\/em>
\n speak<\/em>
\n only<\/em>
\n as of<\/em>
\n the<\/em>
\n date<\/em>
\n of<\/em>
\n this<\/em>
\n press<\/em>
\n release.<\/em>
\n Except<\/em>
\n as<\/em>
\n required<\/em>
\n by<\/em>
\n law,<\/em>
\n we<\/em>
\n assume<\/em>
\n no<\/em>
\n obligation<\/em>
\n to<\/em>
\n update<\/em>
\n forward-looking<\/em>
\n statements<\/em>
\n contained<\/em>
\n in<\/em>
\n this<\/em>
\n press release whether as a result of new information, future events, or otherwise, after the date of this press release.<\/em>\n <\/p>\n

\n Investor Contact:<\/strong>
\n
Candice Masse
astr partners
candice.masse@astrpartners.com<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming scientific and investor conferences in May 2026. Retina World Congress Inherited and Rare Retinal Diseases SessionModerators: Kourous A. Rezaei, MD and Rishi P. Singh, MD, FASRSLocation: Grand BallroomDate: Thursday, May 14, 2026Time: 10:31 am \u2013 11:10 a.m. EDT Stifel 2026 Virtual Ophthalmology Forum Location: VirtualDate: Tuesday, May 26, 2026 Time: 10:30 am \u2013 10:55 a.m. EDT A webcast of the Stifel presentation will be available under the \u201cEvents and Presentation\u201d page of the Investors section of the Company\u2019s … <\/p>\n

Continue reading “Ocugen to Participate in Upcoming May Scientific and Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-962040","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOcugen to Participate in Upcoming May Scientific and Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocugen to Participate in Upcoming May Scientific and Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming scientific and investor conferences in May 2026. Retina World Congress Inherited and Rare Retinal Diseases SessionModerators: Kourous A. Rezaei, MD and Rishi P. Singh, MD, FASRSLocation: Grand BallroomDate: Thursday, May 14, 2026Time: 10:31 am \u2013 11:10 a.m. EDT Stifel 2026 Virtual Ophthalmology Forum Location: VirtualDate: Tuesday, May 26, 2026 Time: 10:30 am \u2013 10:55 a.m. EDT A webcast of the Stifel presentation will be available under the \u201cEvents and Presentation\u201d page of the Investors section of the Company\u2019s … Continue reading "Ocugen to Participate in Upcoming May Scientific and Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-13T11:18:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ocugen to Participate in Upcoming May Scientific and Investor Conferences\",\"datePublished\":\"2026-05-13T11:18:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/\"},\"wordCount\":568,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/\",\"name\":\"Ocugen to Participate in Upcoming May Scientific and Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=\",\"datePublished\":\"2026-05-13T11:18:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocugen to Participate in Upcoming May Scientific and Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocugen to Participate in Upcoming May Scientific and Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Ocugen to Participate in Upcoming May Scientific and Investor Conferences - Market Newsdesk","og_description":"MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming scientific and investor conferences in May 2026. Retina World Congress Inherited and Rare Retinal Diseases SessionModerators: Kourous A. Rezaei, MD and Rishi P. Singh, MD, FASRSLocation: Grand BallroomDate: Thursday, May 14, 2026Time: 10:31 am \u2013 11:10 a.m. EDT Stifel 2026 Virtual Ophthalmology Forum Location: VirtualDate: Tuesday, May 26, 2026 Time: 10:30 am \u2013 10:55 a.m. EDT A webcast of the Stifel presentation will be available under the \u201cEvents and Presentation\u201d page of the Investors section of the Company\u2019s … Continue reading \"Ocugen to Participate in Upcoming May Scientific and Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-13T11:18:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ocugen to Participate in Upcoming May Scientific and Investor Conferences","datePublished":"2026-05-13T11:18:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/"},"wordCount":568,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/","name":"Ocugen to Participate in Upcoming May Scientific and Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=","datePublished":"2026-05-13T11:18:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxOTAwNiM3NTk5Nzg1IzIxODQ1MTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ocugen to Participate in Upcoming May Scientific and Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=962040"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/962040\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=962040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=962040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=962040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}